These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26642342)

  • 1. Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations.
    Snarski E; Milczarczyk A; Hałaburda K; Torosian T; Paluszewska M; Urbanowska E; Król M; Boguradzki P; Jedynasty K; Franek E; Wiktor-Jedrzejczak W
    Bone Marrow Transplant; 2016 Mar; 51(3):398-402. PubMed ID: 26642342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic analysis of autologous hematopoietic stem cell transplantation (AHSCT) in the treatment of new onset type 1 diabetes.
    Snarski E; Szmurło D; Hałaburda K; Król M; Urbanowska E; Milczarczyk A; Franek E; Wiktor-Jedrzejczak W
    Acta Diabetol; 2015 Oct; 52(5):881-8. PubMed ID: 25744552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
    Couri CE; Oliveira MC; Stracieri AB; Moraes DA; Pieroni F; Barros GM; Madeira MI; Malmegrim KC; Foss-Freitas MC; Simões BP; Martinez EZ; Foss MC; Burt RK; Voltarelli JC
    JAMA; 2009 Apr; 301(15):1573-9. PubMed ID: 19366777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
    Obradović D; Tukić L; Radovinović-Tasić S; Petrović B; Elez M; Ostojić G; Balint B
    Vojnosanit Pregl; 2016 May; 73(5):504-8. PubMed ID: 27430119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
    Atkins HL; Bowman M; Allan D; Anstee G; Arnold DL; Bar-Or A; Bence-Bruckler I; Birch P; Bredeson C; Chen J; Fergusson D; Halpenny M; Hamelin L; Huebsch L; Hutton B; Laneuville P; Lapierre Y; Lee H; Martin L; McDiarmid S; O'Connor P; Ramsay T; Sabloff M; Walker L; Freedman MS
    Lancet; 2016 Aug; 388(10044):576-85. PubMed ID: 27291994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
    Voltarelli JC; Couri CE; Stracieri AB; Oliveira MC; Moraes DA; Pieroni F; Coutinho M; Malmegrim KC; Foss-Freitas MC; Simões BP; Foss MC; Squiers E; Burt RK
    JAMA; 2007 Apr; 297(14):1568-76. PubMed ID: 17426276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes.
    Gu W; Hu J; Wang W; Li L; Tang W; Sun S; Cui W; Ye L; Zhang Y; Hong J; Zhu D; Ning G
    Diabetes Care; 2012 Jul; 35(7):1413-9. PubMed ID: 22723579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alleviation of exogenous insulin requirement in type 1 diabetes mellitus after immunoablation and transplantation of autologous hematopoietic stem cells.
    Snarski E; Torosian T; Paluszewska M; Urbanowska E; Milczarczyk A; Jedynasty K; Franek E; Jedrzejczak WW
    Pol Arch Med Wewn; 2009 Jun; 119(6):422-6. PubMed ID: 19694226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for prolonged remission after autologous hematopoietic stem cell transplantation in young patients with type 1 diabetes mellitus.
    Xiang H; Chen H; Li F; Liu J; Su Y; Hao L; Wang F; Wang Z; Zeng Q
    Cytotherapy; 2015 Nov; 17(11):1638-45. PubMed ID: 26318272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I.
    Snarski E; Milczarczyk A; Torosian T; Paluszewska M; Urbanowska E; Król M; Boguradzki P; Jedynasty K; Franek E; Wiktor-Jedrzejczak W
    Bone Marrow Transplant; 2011 Apr; 46(4):562-6. PubMed ID: 20581881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
    Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves β-cell function in Chinese patients with new onset of type 1 diabetes.
    Li L; Shen S; Ouyang J; Hu Y; Hu L; Cui W; Zhang N; Zhuge YZ; Chen B; Xu J; Zhu D
    J Clin Endocrinol Metab; 2012 May; 97(5):1729-36. PubMed ID: 22419704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefits of autologous haematopoietic stem cell transplantation in type 1 diabetes patients.
    Gu B; Miao H; Zhang J; Hu J; Zhou W; Gu W; Wang W; Ning G
    Diabetes Metab; 2018 Sep; 44(4):341-345. PubMed ID: 29331269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis.
    Helbig G; Koclęga A; Woźniczka K; Kopera M; Kyrcz-Krzemień S
    Pathol Oncol Res; 2018 Jul; 24(3):469-475. PubMed ID: 28660547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS.
    Saiz A; Carreras E; Berenguer J; Yagüe J; Martínez C; Marín P; Rovira M; Pujol T; Arbizu T; Graus F
    Neurology; 2001 Apr; 56(8):1084-9. PubMed ID: 11320183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).
    Laurent C; Marjanovic Z; Ricard L; Henes J; Dulery R; Badoglio M; Farge D; Snowden JA; Moraes D; Dias J; Mohty M; Soussan M; Fain O; Arnold R; Alexander T; Oliveira MC; Mekinian A
    Bone Marrow Transplant; 2020 Nov; 55(11):2109-2113. PubMed ID: 32322038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive assessment of T-cell repertoire following autologous hematopoietic stem cell transplantation for treatment of type 1 diabetes using high-throughput sequencing.
    Zhang J; Hu M; Wang B; Gao J; Wang L; Li L; Chen S; Cui B; Gu W; Wang W; Ning G
    Pediatr Diabetes; 2018 Nov; 19(7):1229-1237. PubMed ID: 30022578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus.
    Ye L; Li L; Wan B; Yang M; Hong J; Gu W; Wang W; Ning G
    Stem Cell Res Ther; 2017 Apr; 8(1):90. PubMed ID: 28420440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Insulin Independence in Type 1 Diabetes Mellitus Using a Simplified Autologous Stem Cell Transplant.
    Cantú-Rodríguez OG; Lavalle-González F; Herrera-Rojas MÁ; Jaime-Pérez JC; Hawing-Zárate JÁ; Gutiérrez-Aguirre CH; Mancias-Guerra C; González-Llano O; Zapata-Garrido A; Villarreal-Pérez JZ; Gómez-Almaguer D
    J Clin Endocrinol Metab; 2016 May; 101(5):2141-8. PubMed ID: 26859103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous Hematopoietic Stem Cell Transplantation for Behçet's Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.
    Puyade M; Patel A; Lim YJ; Blank N; Badoglio M; Gualandi F; Ma DD; Maximova N; Greco R; Alexander T; Snowden JA
    Front Immunol; 2021; 12():638709. PubMed ID: 34025648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.